BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 11748973)

  • 1. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
    Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
    Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
    Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
    Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.
    Chan JK; Kapp DS; Shin JY; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Gynecol Oncol; 2008 Jan; 108(1):95-9. PubMed ID: 17949796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.
    Roland PY; Kelly FJ; Kulwicki CY; Blitzer P; Curcio M; Orr JW
    Gynecol Oncol; 2004 Apr; 93(1):125-30. PubMed ID: 15047225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site of oncologic specialty care for older adolescents in Utah.
    Albritton KH; Wiggins CH; Nelson HE; Weeks JC
    J Clin Oncol; 2007 Oct; 25(29):4616-21. PubMed ID: 17925557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of care in advanced ovarian cancer: the importance of provider specialty.
    Mercado C; Zingmond D; Karlan BY; Sekaris E; Gross J; Maggard-Gibbons M; Tomlinson JS; Ko CY
    Gynecol Oncol; 2010 Apr; 117(1):18-22. PubMed ID: 20106512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a gynecologic cancer intergroup trial of the AGO-OVAR and GINECO.
    Pfisterer J; Weber B; Reuss A; Kimmig R; du Bois A; Wagner U; Bourgeois H; Meier W; Costa S; Blohmer JU; Lortholary A; Olbricht S; Stähle A; Jackisch C; Hardy-Bessard AC; Möbus V; Quaas J; Richter B; Schröder W; Geay JF; Lück HJ; Kuhn W; Meden H; Nitz U; Pujade-Lauraine E; ;
    J Natl Cancer Inst; 2006 Aug; 98(15):1036-45. PubMed ID: 16882940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical management of women with ovarian cancer in the south west of England.
    Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J
    Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a regional network for ovarian cancer care.
    van Altena AM; van den Akker PA; de Hullu JA; Ottevanger PB; Aalders AL; Gerritse R; Happel M; Hoekstra MP; Janssen MJ; Samlal RA; Smeets KM; Snijders MP; Vasmel MJ; Vollebergh JH; Kiemeney LA; Massuger LF
    Obstet Gynecol; 2013 Sep; 122(3):668-75. PubMed ID: 23921868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should operate on patients with ovarian cancer? An evidence-based review.
    Giede KC; Kieser K; Dodge J; Rosen B
    Gynecol Oncol; 2005 Nov; 99(2):447-61. PubMed ID: 16126262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of women with gynecologic cancer who enter clinical trials.
    Luck MB; McIntire M; Blades N; Robinson W
    J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
    Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
    Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
    Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
    Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
    Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
    J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.